Hawaii · 2026 Regular Session · Bill
SB 2221: RELATING TO TERMINAL ILLNESSES.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 2221 is a bill introduced in the Hawaii Senate on January 14, 2026. According to its official title, it concerns: RELATING TO TERMINAL ILLNESSES. Primary sponsor: Stanley Chang (Democratic), Kurt Fevella (Republican). It lists 1 additional sponsor. Most recent recorded action (January 26, 2026): Referred to HHS, CPN/JDC.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions.
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Stanley Chang | Primary sponsor | Democratic | Senate | 9 |
| Kurt Fevella | Primary sponsor | Republican | Senate | 20 |
| Joy San Buenaventura | Co-sponsor | Democratic | Senate | 2 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to HHS, CPN/JDC.
- Introduced and passed First Reading.
- Pending Introduction.